Limited neuropeptide Y precursor processing in unfavourable metastatic neuroblastoma tumours
2000
Neuropeptide Y Processing in Neuroblastoma Tumours
Sample size: 18
publication
Evidence: moderate
Author Information
Author(s): Bjellerup P, Theodorsson E, Jörnvall H, Kogner P
Primary Institution: Karolinska Institutet and Karolinska Hospital
Hypothesis
The study investigates the processing of neuropeptide Y (NPY) in neuroblastoma tumours and its correlation with clinical outcomes.
Conclusion
A low degree of proNPY processing is associated with advanced clinical stage and poor outcomes in neuroblastomas.
Supporting Evidence
- Intact NPY was found in all tumours, while proNPY was only detected in control tissue and malignant neuroblastomas.
- Lower proNPY processing was observed in advanced neuroblastomas compared to less aggressive stages.
- ProNPY processing of less than 50% correlated with poor clinical outcomes.
Takeaway
The study found that in some cancerous tumours, a specific protein is not processed properly, which can mean the cancer is more serious.
Methodology
The study used gel-permeation chromatography to analyze NPY and proNPY processing in tumour samples.
Participant Demographics
The study included neuroblastoma samples from different clinical stages.
Statistical Information
P-Value
P = 0.012
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website